‘Landmark’ Schizophrenia Drug in the Wings?
A novel therapy that combines a muscarinic receptor agonist with an anticholinergic agent is associated with a greater reduction in […]
A novel therapy that combines a muscarinic receptor agonist with an anticholinergic agent is associated with a greater reduction in […]extrapyramidal symptoms
‘Landmark’ Schizophrenia Drug in the Wings?
Copyright © 2024